Novartis AG ADR

Merck Fights Medicare Drug-Price Negotiations in Court

2:58 p.m. June 6, 2023

- Barron's Online

Biotech stocks could soon get a M&A boost. Here are 3 likely takeover plays.

3:17 p.m. June 5, 2023

- Michael Brush

You can’t rely on indexes to pick international stocks, this 5-star fund manager says. Here are 3 of his top selections.

12:35 p.m. May 31, 2023

- Philip van Doorn

Novartis Dropping Some Cancer Drugs From Pipeline

12:06 p.m. May 19, 2023

- Barron's Online

J&J’s Kenvue Spinoff: A Rare IPO Winner in a Moribund Market

10:25 a.m. May 4, 2023

- Barron's Online

Novartis raises 2023 view, after posting higher profit and sales

1:44 a.m. April 25, 2023

- Cecilia Butini

The FDA Is Resuming Drug Lab Inspections in China. These Biotechs Could Benefit.

2:45 p.m. April 14, 2023

- Barron's Online

Threats Mount to Dollar’s Role as World’s Reserve Currency

9:30 p.m. April 14, 2023

- Barron's Online

There’s another looming cliff — the end of the student-loan repayment moratorium

7:57 a.m. March 28, 2023

- Steve Goldstein

First Citizens, First Republic, Coinbase, Blackbaud, Carnival, and More Stock Market Movers

4:14 p.m. March 27, 2023

- Barron's Online

First Citizens’ stock leaps on SVB deal, Carnival share drop after downbeat outlook, and other stocks on the move

2:09 p.m. March 27, 2023

- Steve Goldstein

Pfizer eyes takeover of biotech Seagen, at value of more than $30 billion

11:26 p.m. Feb. 26, 2023

This chart offers one reason that European stocks may continue to outperform U.S. equities

8:45 a.m. Feb. 17, 2023

- Steve Goldstein

Novartis posts lower sales and profit on generic competition, but boosts 2022 dividend

2:39 a.m. Feb. 1, 2023

- Cecilia Butini

Apple, Amazon, Fed Decision, Jobs, and More

5:05 a.m. Feb. 6, 2023

- Barron's Online

Gasoline Prices Are Rising. A Major Beneficiary: Refiners.

12:04 p.m. Jan. 28, 2023

- Barron's Online

The Year's Biggest Healthcare Conference Starts Today

9:47 a.m. Jan. 9, 2023

- Barron's Online

Yield-Hungry Investors, You’re In Luck. Where to Find Income in 2023.

6:48 p.m. Jan. 6, 2023

- Barron's Online

Powell Cancels the Santa Rally. Here’s Hoping 2023 Is Better.

7:51 a.m. Dec. 16, 2022

- Barron's Online

Cooper Cos. stock rises Friday, outperforms market

5:40 p.m. Nov. 25, 2022

- MarketWatch Automation

10-Q: LIGAND PHARMACEUTICALS INC

4:09 p.m. May 8, 2023

- Edgar Online - (EDG = 10Q, 10K)

Can a Kidney Transplant Drug Keep You From Aging?

10:57 a.m. May 1, 2023

- The Wall Street Journal Interactive Edition

The ‘King Kong’ of Weight-Loss Drugs Is Coming

11:03 a.m. June 2, 2023

- The Wall Street Journal Interactive Edition

Shortage of Last-Ditch Drug for Advanced Prostate Cancer Worries Doctors

2:33 a.m. March 17, 2023

- The Wall Street Journal Interactive Edition

Seagen’s Cancer Therapy Is Making It a Takeover Target

8:44 a.m. June 5, 2023

- The Wall Street Journal Interactive Edition

Pfizer Is in Early-Stage Talks to Acquire Seagen

2:18 p.m. May 31, 2023

- The Wall Street Journal Interactive Edition

LOOMIS SAYLES & CO L P Buys 2, Sells 3 in 4th Quarter

9:00 a.m. Feb. 12, 2023

- GuruFocus.com

Pfizer, Novartis, Merck Executives Say They Are Hunting for Deals Again

3:35 a.m. Feb. 10, 2023

- The Wall Street Journal Interactive Edition

Top 5 4th Quarter Trades of BUCKHEAD CAPITAL MANAGEMENT LLC

9:00 p.m. Feb. 8, 2023

- GuruFocus.com

Top 5 4th Quarter Trades of NICHOLS & PRATT ADVISERS LLP /MA

3:00 p.m. Feb. 3, 2023

- GuruFocus.com

Drug Prices Rise 5.6% as U.S. Ramps Up Pressure to Lower Costs

10:48 a.m. June 5, 2023

- The Wall Street Journal Interactive Edition

Top 5 4th Quarter Trades of Veriti Management LLC

7:00 p.m. Jan. 20, 2023

- GuruFocus.com

GE’s Spinoff Deserves Healthy Skepticism

6:43 p.m. Jan. 8, 2023

- The Wall Street Journal Interactive Edition

CONFLUENCE INVESTMENT MANAGEMENT LLC Buys 1, Sells 4 in 4th Quarter

9:00 a.m. Jan. 4, 2023

- GuruFocus.com

Drug Prices Reach New High—in the Millions

1:31 p.m. June 5, 2023

- The Wall Street Journal Interactive Edition

Surprising Results Could Put This Biotech in Big Pharma’s Sights

3:33 a.m. Dec. 20, 2022

- The Wall Street Journal Interactive Edition

Clovis Enters Bankruptcy With Deal to Sell Cancer-Drug Candidate to Novartis

5:53 p.m. Dec. 13, 2022

- The Wall Street Journal Interactive Edition

Clovis (CLVS) Files for Bankruptcy Amid Lack of Financial Aid

11:38 a.m. Dec. 12, 2022

- Zacks.com

Europe Hit by Shortages of Antibiotics

9:00 a.m. Dec. 10, 2022

- The Wall Street Journal Interactive Edition

Pharma Stock Roundup: SNY, GSK, PFE Relieved on Zantac Win & Other Updates

10:16 a.m. Dec. 9, 2022

- Zacks.com